Pubdate: Fri, 11 Jan 2002 Source: Ottawa Citizen (CN ON) Copyright: 2002 The Ottawa Citizen Contact: http://www.canada.com/ottawa/ottawacitizen/ Details: http://www.mapinc.org/media/326 Forum: http://discussion.canada.com/user/forums.asp Authors: Mike Trickey and Mark Kennedy Bookmark: http://www.mapinc.org/meth.htm (Methamphetamine) CANADA FUELS U.S. MARKET FOR 'SPEED' Lax laws Fail To Track Supplies Of Key Chemical In Street Drug WASHINGTON -- The U.S. says Canada must tighten laws on buying and selling a chemical used in cold medicine after a year-long criminal investigation revealed Canada to be the largest supplier to the U.S. of the main ingredient in methamphetamine -- better known as speed. U.S. federal agents carried out a series of raids across the country yesterday, arresting more than 50 people in connection with a smuggling operation that depends on what U.S. officials say are lax Canadian regulations. Canadian law does not require firms selling pseudoephedrine, a chemical commonly used in cold and allergy medicines, but also a key ingredient in methamphetamine, to do checks on customers or determine final usage of the product. Two drug-smuggling operations, one based in Chicago and the other in Detroit, have used the loophole to legally purchase tonnes of pseudoephedrine in Canada from two Quebec-based companies -- Frega and Formulex -- and then smuggle it illegally into the U.S. The chemical is then sold to groups, primarily Mexican crime organizations, which use it to produce cheap illicit street drugs. U.S. officials said nearly 100 per cent of the methamphetamine produced in the country in the past two years has its origins in Canada. Nearly all of the arrests made yesterday were of Middle Eastern men, primarily from Jordan and Iran, involved in two large-scale drug smuggling and production rings. Asa Hutchison, head of the U.S. Drug Enforcement Administration, says much of the drug profits were being funnelled back to the Middle East, but investigators had not uncovered any evidence that the money was being used to fund terrorism. Mr. Hutchison emphasized several times that no Canadians were involved in illegal activities, and praised Canadian customs officials and the RCMP for their co-operation. He said a tip from the RCMP in October resulted in Americans tracing the movements of smugglers and ultimately seizing 37 million tablets in California. However, comments by American officials raised concerns about whether Quebec pharmaceutical suppliers knew the product they were supplying was being used for illegal purposes. Referring to a bust last April in which U.S. customs officials seized 43 million tablets -- about 12 tonnes of pseudoephedrine -- at the Ambassador Bridge between Detroit and Windsor, U.S. Customs boss Robert Bonner said questions had to be raised about the amount of product being purchased. "There was enough decongestant in that truck to unplug every nose in Michigan for several years," he said. During the operation dubbed Mountain Express III, American agents seized 110 million pseudoephedrine tablets in eight different seizures, which officials estimated would produce up to 9,000 pounds of methamphetamine. DEA officials say methamphetamine has a street value of about $12,000 a pound. The seizure of 110 million pseudoephedrine tablets represents 25 per cent of the total amount of the product imported into Canada in the past year. Seven of the seizures occurred along the Ontario-Michigan border, while one was at Grande Portage, Minnesota, south of Thunder Bay. The pills, which are sold commercially in bottles of 50 or 100 units, were being shipped by smugglers in increasingly large containers. In a bust late last year, drug enforcement officers found the pills being shipped in seven-gallon cans containing 80,000 pills each. The Americans say Canadian imports of pseudoephedrine have increased by 1,400 per cent since the mid-1990s. Asked if he thought the Canadian companies were knowingly turning a blind eye to the fact that they are obviously selling more pseudoephedrine than could be consumed in Canada and in essence profiting from illegal drug production, Mr. Hutchison was diplomatic. "Well, you'd be asking me to judge intent and motive, and I don't believe I am in a position to do that." Mr. Bonner said Canada must change its laws, as the U.S. did several years ago, to make it illegal to divert pseudoephedrine for illegitimate uses. "The question here is diversion for illegal manufacture. Right now in Canada they do not have, in my judgment, adequate laws and regulations to protect against the illegal diversion of pseudoephedrine. I understand that the Canadians, the government at the political level, is aware of this problem, and I have been advised that they are taking steps to strengthen their laws and regulations to make it more difficult -- much more difficult -- for this kind of illegal diversion." He said Canadian law should require corporations to look at how much pseudoephedrine they are importing and whether that amount matches the amount needed by the Canadian population. As well, he called for bulk distributors to be adequately identified and registered and that information be given on the end use of the chemical. Yesterday in Ottawa, federal officials acknowledged the smuggling of pseudoephedrine to the U.S. for the production of illegal drugs constitutes a major problem. Spokesmen from Health Canada, the RCMP and Canada Customs said the government plans to implement new regulations by the end of this year to "monitor and control" the growing problem. "Clearly the diversion of legal chemicals, including pseudoephedrine, from Canada for illicit use is of concern to the RCMP," said Sgt. Paul Marsh, a spokesman for the Mounties. He said the RCMP has been working closely with the U.S. Drug Enforcement Administration to "dismantle" several pseudoephedrine "trafficking networks" that have sprung up in recent years. Sgt. Marsh said Canadian companies legally import the raw powder for pseudoephedrine from several countries, mainly China, India, Germany and the Czech Republic. The companies then manufacture the powder into pills to be used for legally available cold remedies. At some point afterwards, he said, the pills are "diverted" and exported to the U.S., where they are used for the production of illicit drugs such as methamphetamine. Sgt. Marsh said "it can be challenging for the law-enforcement community because there are no regulations at the present time to monitor the exportation and how the pseudoephedrine is being distributed in Canada." In the absence of that "official" monitoring system, he said, the RCMP keeps in close touch with Canadian companies that manufacture chemicals "to keep track of what the trends are." But ultimately, he said "there is no requirement for these companies to report to law enforcement officials." One of the Canadian firms that legally manufactures and sells pseudoephedrine is Montreal-based Formulex Canada. Sonia Riopelle, a spokeswoman for the firm, said yesterday that the company follows all of the rules required of it by Health Canada. She said that when the company sells its products to another firm, it must keep records that indicate the purchasing order and shipping order, as well as proof that the buyer has a drug identification number that permits it to make the purchase. "The only thing that (Health Canada) is requiring is that we keep a log book with everything that's been purchased and sold." She said nothing obliges Formulex to know what the buyer ultimately does with the product. "As far as we're concerned, it's supposed to be used for decongestant," she said. But the buyer is "responsible for what he does with his product. "We manufacture it, but what they do with it, it's their responsibility." Asked if this opens the door for possible misuse of the product by a buyer, Ms. Riopelle replied: "That is quite possible. I cannot guarantee. It might be exported and then resold. I have no idea." Collette Gentes-Hawn of Canada Customs said there is nothing her department can do to stop the exports of the product, because it is not deemed a controlled substance. Several government departments, as well as private companies, have been involved in a group led by Health Canada to tighten the regulations. Health Canada official Carole Bouchard said the government is developing a comprehensive regulatory framework under the Controlled Drugs and Substances Act that would put pseudoephedrine under tighter control. But she said discussions are still under way and could not provide details on how the regulations will be formed, including whether they would include a specific provision that forces manufacturers of pseudoephedrine to know what their buyers do with the product. In addition to the mandatory regulations, she said it's possible that a voluntary "code of conduct" will be developed for the industry. - --- MAP posted-by: Josh